LED Medical Diagnostics Launches New TUXEDO(TM) Intraoral Sensor
Marketwired
ATLANTA, GA--(Marketwired - May 12, 2016) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD)(LEDIF)(LME.F) ("LED Medical" or "the Company") has announced that its subsidiary, LED Dental, has officially launched the TUXEDO™ Intraoral Sensor, a new high-definition digital radiography system with a five-year, deductible-free warranty program. As the latest dental imaging product from LED Dental, the TUXEDO Intraoral Sensor not only delivers crystal clear digital intraoral radiographs, but also breaks away from the industry norm of additional monthly support fees and expensive warranty deductible costs.
"We have designed the TUXEDO sensor to deliver exceptional image quality, long-term durability and a low total cost-of-ownership," said Jeffrey Brooks, D.M.D., Vice President of Imaging for LED Dental. "Our hope is to remove any financial barriers to the adoption of digital technology while providing a solution that is unmatched in both performance and affordability."
With true image resolution of >20 lp/mm, the intraoral radiographs produced by the TUXEDO Intraoral Sensor are among the highest resolution in the industry. Seamless integration with LED Imaging Cloud software allows for secure cloud back-up along with custom imaging filters for a variety of clinical needs, optimizing sharpness and contrast for endodontics, periodontics and caries diagnosis.
The standard five-year warranty included with every TUXEDO Intraoral Sensor is a new, all-inclusive approach that separates LED Dental's sensor from many similar digital radiography systems across the industry. Customers will receive five years of coverage with no replacement deductibles and no monthly fees for technical support.
"Our company prides itself on providing a white-glove service experience for our customers," stated Dr. David Gane, CEO of LED Medical Diagnostics. "When a practice invests in the TUXEDO Intraoral Sensor, they will get state-of-the-art technology backed by a warranty program that is second to none, without additional support fees or surprise warranty deductibles."
The name TUXEDO was chosen to reflect the high-end performance of the sensor, while evoking LED Dental's commitment to "white-glove" service.
Dr. Gane concluded, "The goal of our company is to think outside of the box, creating innovative approaches to existing technologies, both from a performance and value perspective. I believe the Tuxedo Intraoral Sensor definitely delivers on both of these objectives."
The TUXEDO Intraoral Sensor will be available for demonstration in booth 2234 during the California Dental Association Presents Anaheim trade show, May 12-14, 2016. For more information on LED Dental and the launch of the new TUXEDO Intraoral Sensor, please visit www.leddental.com or call 844.952.7327.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol "LMD," the OTCQX under the symbol "LEDIF," as well as the Frankfurt Stock Exchange under the symbol "LME." For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2015. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
